NASDAQ:MRAI Marpai (MRAI) Stock Price, News & Analysis → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free MRAI Stock Alerts $0.64 +0.14 (+27.97%) (As of 05/31/2024 ET) Add Compare Share Share Today's Range$0.45▼$0.6950-Day Range$0.50▼$2.8152-Week Range$0.33▼$3.46Volume204,242 shsAverage Volume146,916 shsMarket Capitalization$6.60 millionP/E RatioN/ADividend YieldN/APrice Target$6.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Marpai alerts: Email Address Marpai MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside836.7% Upside$6.00 Price TargetShort InterestHealthy0.22% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.70Based on 6 Articles This WeekInsider TradingAcquiring Shares$1.51 M Bought Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.3.15 out of 5 stars 3.5 Analyst's Opinion Consensus RatingMarpai has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageMarpai has only been the subject of 1 research reports in the past 90 days.Read more about Marpai's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.22% of the float of Marpai has been sold short.Short Interest Ratio / Days to CoverMarpai has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Marpai has recently decreased by 84.71%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldMarpai does not currently pay a dividend.Dividend GrowthMarpai does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for MRAI. Previous Next 2.1 News and Social Media Coverage News SentimentMarpai has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Business Services companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Marpai this week, compared to 1 article on an average week.Search InterestOnly 3 people have searched for MRAI on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Marpai to their MarketBeat watchlist in the last 30 days. This is a decrease of -87% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Marpai insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,514,125.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders61.30% of the stock of Marpai is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions49.75% of the stock of Marpai is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Marpai's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Marpai is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Marpai is -0.20, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Marpai's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad InvestorPlaceWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details About Marpai Stock (NASDAQ:MRAI)Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.Read More MRAI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MRAI Stock News HeadlinesMay 28, 2024 | investorplace.comWhy Is Marpai (MRAI) Stock Down 41% Today?May 24, 2024 | prnewswire.comMARPAI ANNOUNCES WITHDRAWAL FROM NASDAQ HEARINGS PROCESS AND WILL TRANSITION TRADING TO THE OTCQX MARKETMay 21, 2024 | prnewswire.comSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Marpai, Inc. (NASDAQ: MRAI)May 13, 2024 | finance.yahoo.comMarpai Inc (MRAI) Q1 2024 Earnings Call Transcript Highlights: Strategic Shifts and Financial ...May 11, 2024 | markets.businessinsider.comMarpai’s Strategic Turnaround and Growth Potential Justify Buy RatingMay 11, 2024 | finance.yahoo.comMarpai, Inc. (NASDAQ:MRAI) Q1 2024 Earnings Call TranscriptMay 9, 2024 | investorplace.comMRAI Stock Earnings: Marpai Reported Results for Q1 2024May 9, 2024 | prnewswire.comMARPAI REPORTS FIRST QUARTER 2024 FINANCIAL RESULTSMay 3, 2024 | prnewswire.comMARPAI TO HOST WEBCAST ON MAY 10, 2024 TO DISCUSS FIRST QUARTER 2024 FINANCIAL RESULTSMay 2, 2024 | prnewswire.comMARPAI INC. ANNOUNCES COST REDUCTION PROGRAM AND PROPERTY SUBLEASEApril 24, 2024 | prnewswire.comMARPAI INC. BOLSTERS SALES TEAM WITH TWO WORLD-CLASS EXECUTIVESApril 18, 2024 | investing.comMarpai secures $11.83 million in convertible notesApril 16, 2024 | prnewswire.comMARPAI INC. ANNOUNCES SALE OF $11.83 MILLION CONVERTIBLE NOTESApril 4, 2024 | benzinga.comMarpai Stock (NASDAQ:MRAI), Quotes and News SummaryMarch 29, 2024 | seekingalpha.comMarpai, Inc. (MRAI) Q4 2023 Earnings Call TranscriptMarch 29, 2024 | investing.comEarnings call: Marpai reports mixed Q4 and FY 2023 financial resultsMarch 29, 2024 | finance.yahoo.comQ4 2023 Marpai Inc Earnings CallMarch 28, 2024 | finance.yahoo.comMarpai, Inc. (NASDAQ:MRAI) Q4 2023 Earnings Call TranscriptMarch 27, 2024 | finance.yahoo.comMARPAI REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTSMarch 13, 2024 | finance.yahoo.comNASDAQ PANEL GRANTS MARPAI'S REQUEST FOR EXTENSION TO COMPLY WITH CONTINUED LISTING REQUIREMENTSMarch 7, 2024 | investing.comMarpai secures deal to expand in the Southeast marketMarch 6, 2024 | finance.yahoo.comMARPAI ANNOUNCES "OFF-CYCLE" NEW CLIENT AGREEMENTMarch 6, 2024 | finance.yahoo.comMARPAI ANNOUNCES PRELIMINARY UNAUDITED FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023February 9, 2024 | markets.businessinsider.comMarpai Adjusts AXA Deal Terms, Sells Future ReceiptsFebruary 8, 2024 | finance.yahoo.comMARPAI ANNOUNCES KEY FINANCIAL AGREEMENTSSee More Headlines Receive MRAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Marpai and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Today6/01/2024Next Earnings (Estimated)8/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorBusiness Services Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryN/A Current SymbolNASDAQ:MRAI CUSIPN/A CIK1844392 Webwww.marpaihealth.com Phone646-303-3483FaxN/AEmployees162Year FoundedN/APrice Target and Rating Average Stock Price Target$6.00 High Stock Price Target$6.00 Low Stock Price Target$6.00 Potential Upside/Downside+836.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($3.19) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-28,750,000.00 Net Margins-69.48% Pretax Margin-70.31% Return on EquityN/A Return on Assets-68.67% Debt Debt-to-Equity RatioN/A Current Ratio0.82 Quick Ratio0.82 Sales & Book Value Annual Sales$37.15 million Price / Sales0.18 Cash FlowN/A Price / Cash FlowN/A Book Value($1.41) per share Price / Book-0.45Miscellaneous Outstanding Shares10,310,000Free Float3,989,000Market Cap$6.60 million OptionableNo Data Beta5.39 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Damien Francis Lamendola (Age 67)CEO & Director Mr. Steve Johnson (Age 53)CFO & Company Secretary Mr. John Powers (Age 56)President & COO Dr. Eli David (Age 42)Co-Founder & Chief Science Advisor Ms. Pamela BurnsVice President of Enterprise SalesMr. Richard BrewerChief Strategy OfficerMore ExecutivesKey CompetitorsOntrakNASDAQ:OTRKMangoceuticalsNASDAQ:MGRXBioRestorative TherapiesNASDAQ:BRTXGreenbrook TMSNASDAQ:GBNHFSPAR GroupNASDAQ:SGRPView All CompetitorsInsidersSteve Andrew JohnsonBought 3,500 shares on 5/29/2024Total: $2,275.00 ($0.65/share)Robert M PonsBought 5,000 shares on 5/28/2024Total: $4,350.00 ($0.87/share)Steve Andrew JohnsonBought 5,000 shares on 5/24/2024Total: $6,000.00 ($1.20/share)Damien LamendolaBought 910,000 shares on 3/7/2024Total: $1.50 M ($1.65/share)Damien LamendolaBought 1,100,000 shares on 1/16/2024Total: $1.01 M ($0.92/share)View All Insider Transactions MRAI Stock Analysis - Frequently Asked Questions Should I buy or sell Marpai stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Marpai in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MRAI shares. View MRAI analyst ratings or view top-rated stocks. What is Marpai's stock price target for 2024? 1 brokers have issued 12 month price targets for Marpai's shares. Their MRAI share price targets range from $6.00 to $6.00. On average, they anticipate the company's share price to reach $6.00 in the next twelve months. This suggests a possible upside of 836.7% from the stock's current price. View analysts price targets for MRAI or view top-rated stocks among Wall Street analysts. How have MRAI shares performed in 2024? Marpai's stock was trading at $1.75 at the beginning of the year. Since then, MRAI shares have decreased by 63.4% and is now trading at $0.6406. View the best growth stocks for 2024 here. Are investors shorting Marpai? Marpai saw a decrease in short interest in May. As of May 15th, there was short interest totaling 11,500 shares, a decrease of 84.7% from the April 30th total of 75,200 shares. Based on an average daily trading volume, of 406,200 shares, the days-to-cover ratio is presently 0.0 days. Approximately 0.2% of the shares of the stock are sold short. View Marpai's Short Interest. When is Marpai's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024. View our MRAI earnings forecast. How were Marpai's earnings last quarter? Marpai, Inc. (NASDAQ:MRAI) released its earnings results on Thursday, May, 9th. The company reported ($0.46) earnings per share (EPS) for the quarter. The business earned $7.39 million during the quarter. When did Marpai's stock split? Marpai shares reverse split before market open on Thursday, June 29th 2023. The 1-4 reverse split was announced on Thursday, June 29th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 29th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. What guidance has Marpai issued on next quarter's earnings? Marpai issued an update on its FY 2023 earnings guidance on Wednesday, March, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $37.2 million-$37.2 million, compared to the consensus revenue estimate of $34.6 million. When did Marpai IPO? Marpai (MRAI) raised $25 million in an IPO on Wednesday, October 27th 2021. The company issued 6,300,000 shares at a price of $4.00 per share. ThinkEquity served as the underwriter for the IPO. How do I buy shares of Marpai? Shares of MRAI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:MRAI) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
